Annals of Oncology

News:

Has Hodgkin's disease finally been conquered, in the bicentennial year of its describer's birth ?
Ann Oncol 9: 575-576.
[PDF] [Request Permissions]

Germany to follow Switzerland in distributing heroin?
Ann Oncol 9: 576.
[PDF] [Request Permissions]

Shoul Silicone implandts be banned in Europe?
Ann Oncol 9: 576.
[PDF] [Request Permissions]

Australian Cancer Society names new Chief Executive Officer
Ann Oncol 9: 576-577.
[PDF] [Request Permissions]

Are American cancer data racially biased?
Ann Oncol 9: 577.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 9: 577-579.
[PDF] [Request Permissions]

Book reviews:

D. May and N. de Tribolet

Book review
Ann Oncol 9: 580.
[PDF] [Request Permissions]

F. Jungi

Book review
Ann Oncol 9: 682.
[PDF] [Request Permissions]

Editorial:

P. Boyle and P. Autier

Colorectal cancer screening: Health policy or a continuing research issue?
Ann Oncol 9: 581-584.
[PDF] [Request Permissions]

Special articles:

D. J. Th. Wagener, J. B. Vermorken, H. H. Hansen, and D. K. Hossfeld

The ESMO programme of certification and training for medical oncology
Ann Oncol 9: 585-587.
[Abstract] [PDF] [Request Permissions]

Review:

P. Hösli, A. P. Sappino, N. de Tribolet, and P. Y. Dietrich

Malignant glioma: Should chemotherapy be overthrown by experimental treatments?
Ann Oncol 9: 589-600.
[Abstract] [PDF] [Request Permissions]

Review on evidence-based cancer medicine:

C. J. Williams

The pitfalls of narrative reviews in clinical medicine
Ann Oncol 9: 601-605.
[PDF] [Request Permissions]

Commentary:

S. A. Pileri, M. Milani, G. Fraternali-Orcioni, E. Sabattini, and See Appendix on page 611 for members of the International Lymphoma Study Group

From the R.E.A.L. Classification to the upcoming WHO scheme: A step toward universal categorization of lymphoma entities?
Ann Oncol 9: 607-612.
[PDF] [Request Permissions]

Original articles:

J. Norum

Prevention of colorectal cancer: A cost-effectiveness approach to a screening model employing sigmoidoscopy
Ann Oncol 9: 613-618.
[Abstract] [PDF] [Request Permissions]

R. Bouabdallah, L. Xerri, V.-J. Bardou, A.-M. Stoppa, D. Blaise, D. Sainty, D. Maraninchi, and J.-A. Gastaut

Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: A report on 62 patients from a single center
Ann Oncol 9: 619-625.
[Abstract] [PDF] [Request Permissions]

D. Perotti, P. Mondini, R. Giardini, A. Ferrari, M. Massimino, F. Gambirasio, M. A. Pierotti, F. Fossati-Bellani, and P. Radice

No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys–Drash syndrome
Ann Oncol 9: 627-631.
[Abstract] [PDF] [Request Permissions]

N. P. Bailey, N. S. A. Stuart, E. M. Bessell, J. A. Child, D. Norfolk, J. Fletcher, R. J. Grieve, A. V. Simmons, D. L. Barnard, A. Jack, J. Farish, J. Dunn, C. M. Woodroffe, C. Stack, M. H. Cullen, and on behalf of the Central Lymphoma Group

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma
Ann Oncol 9: 633-638.
[Abstract] [PDF] [Request Permissions]

M. Gershanovich, H. A. Chaudri, D. Campos, H. Lurie, A. Bonaventura, M. Jeffrey, F. Buzzi, I. Bodrogi, H. Ludwig, P. Reichardt, N. O'Higgins, G. Romieu, P. Friederich, M. Lassus, and Letrozole International Trial Group (AR/BC3)

Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer
Ann Oncol 9: 639-645.
[Abstract] [PDF] [Request Permissions]

P. C. Hoffman, D. J. Haraf, M. K. Ferguson, L. C. Drinkard, and E. E. Vokes

Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: A long-term analysis
Ann Oncol 9: 647-651.
[Abstract] [PDF] [Request Permissions]

M. Ducreux, P. Rougier, A. Fandi, M.-C. Clavero-Fabri, A.-L. Villing, F. Fassone, L. Fandi, J. Zarba, and J.-P. Armand

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin
Ann Oncol 9: 653-656.
[Abstract] [PDF] [Request Permissions]

T. B. Christensen, G. Daugaard, P. F. Geertsen, and H. von der Maase

Effect of chemotherapy on carcinoma in situ of the testis
Ann Oncol 9: 657-660.
[Abstract] [PDF] [Request Permissions]

L. Goedhals, J.-F. Heron, J.-P. Kleisbauer, O. Pagani, and C. Sessa

Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study
Ann Oncol 9: 661-666.
[Abstract] [PDF] [Request Permissions]

Clinical case:

H. Schefer, S. Mattmann, and R. A. Joss

Hereditary persistence of -fetoprotein: Case report and review of the literature
Ann Oncol 9: 667-672.
[Abstract] [PDF] [Request Permissions]

Short report:

V. Conter, B. Tschümperlin, B. Gridelli, A. Lucianetti, S. Ascani, D. Bauer, R. Burnelli, S. Poggi, V. Ramaccioni, M. Milani, and S. A. Pileri

Hodgkin's disease occurring in a child after liver transplantation
Ann Oncol 9: 673-676.
[Abstract] [PDF] [Request Permissions]

G. A. Masters, A. M. Mauer, Ph. C. Hoffman, D. Wyka, B. L. Samuels, S. A. Krauss, S. Watson, H. Golomb, and E.E. Vokes

A phase I–II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer
Ann Oncol 9: 677-680.
[Abstract] [PDF] [Request Permissions]

Letter to the editor:

M. Dobbie, S. Hofer, M. Oberholzer, and R. Herrmann

Veno-occlusive disease of the liver induced by gemcitabine
Ann Oncol 9: 681.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.